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Abstract
Objective To evaluate the association between body mass index and
mortality from overall cardiovascular disease and specific subtypes of
cardiovascular disease in east and south Asians.
Design Pooled analyses of 20 prospective cohorts in Asia, including
data from 835 082 east Asians and 289 815 south Asians. Cohorts were
identified through a systematic search of the literature in early 2008,
followed by a survey that was sent to each cohort to assess data
availability.
Setting General populations in east Asia (China, Taiwan, Singapore,
Japan, and Korea) and south Asia (India and Bangladesh).
Participants 1 124 897 men and women (mean age 53.4 years at
baseline).
Main outcome measures Risk of death from overall cardiovascular
disease, coronary heart disease, stroke, and (in east Asians only) stroke
subtypes.
Results 49 184 cardiovascular deaths (40 791 in east Asians and 8393
in south Asians) were identified during a mean follow-up of 9.7 years.
East Asians with a body mass index of 25 or above had a raised risk of
death from overall cardiovascular disease, compared with the reference
range of body mass index (values 22.5-24.9; hazard ratio 1.09 (95%
confidence interval 1.03 to 1.15), 1.27 (1.20 to 1.35), 1.59 (1.43 to 1.76),
1.74 (1.47 to 2.06), and 1.97 (1.44 to 2.71) for body mass index ranges
25.0-27.4, 27.5-29.9, 30.0-32.4, 32.5-34.9, and 35.0-50.0, respectively).
This association was similar for risk of death from coronary heart disease
and ischaemic stroke; for haemorrhagic stroke, the risk of death was
higher at body mass index values of 27.5 and above. Elevated risk of
death from cardiovascular disease was also observed at lower categories
of body mass index (hazard ratio 1.19 (95% confidence interval 1.02 to
1.39) and 2.16 (1.37 to 3.40) for body mass index ranges 15.0-17.4 and
<15.0, respectively), compared with the reference range. In south Asians,
the association between body mass index and mortality from
cardiovascular disease was less pronounced than that in east Asians.
South Asians had an increased risk of death observed for coronary heart
disease only in individuals with a body mass index greater than 35
(hazard ratio 1.90, 95% confidence interval 1.15 to 3.12).
Conclusions Body mass index shows a U shaped association with
death from overall cardiovascular disease among east Asians: increased
risk of death from cardiovascular disease is observed at lower and higher
ranges of body mass index. A high body mass index is a risk factor for
mortality from overall cardiovascular disease and for specific diseases,
including coronary heart disease, ischaemic stroke, and haemorrhagic
stroke in east Asians. Higher body mass index is a weak risk factor for
mortality from cardiovascular disease in south Asians.
Introduction
Cardiovascular disease (CVD) is the leading cause of death
globally.1 CVD incidence is predicted to increase steadily over
the next few decades.2 Between 1990 and 2020, the increase in
death from coronary heart disease (CHD) is expected to be 120%
inwomen and 137% inmen in low andmiddle income countries,
and 29% and 48%, respectively, among high income countries.
A similar pattern for increases in stroke mortality is predicted.3
Asian countries in general have higher rates of stroke
mortality—especially death from haemorrhagic stroke—than
Western countries, although these rates have decreased in Japan
and urban areas in China.4 5 With regard to CHD, east Asian
countries have a lower mortality than Western countries,
whereas south Asian countries have a higher mortality.4
Cardiovascular risk factors including hypertension, diabetes,
tobacco use, dyslipidaemia, and overweight are traditionally
derived from studies conducted in Europe and North America.
Owing to differing experiences at various stages of
epidemiological transition and urbanisation—with varied life
expectancy, diverse demographic profiles, as well as differences
in environmental and genetic risk factors—the relations between
these risk factors and CVDmortality may differ between Asian
and Western societies.6 Migrant studies show that Japanese
Americans have higher CHD rates and lower stroke rates7 8 than
Japanese people living in Japan.9 Likewise, increased risk of
CHD has been reported in migrant south Asians.10Among south
Asians, those who migrated from rural to urban areas of their
native countries also have a greater prevalence of obesity and
lower level of physical activity than those who resided in rural
areas.11 12
Overweight and obesity are increasingly globally. Many Asian
populations used to be physically active with a low body mass
index (BMI), but the region now has some of the world’s highest
rates of obesity.1 Several meta-analyses have been conducted
to evaluate associations between BMI and stroke and CHD
mortality,13-17 based mostly on studies in Western populations.
Several prospective studies of BMI and CVD risk have been
conducted in east Asians.18-20 However, no data have been
available to compare east and south Asians for any potential
differences in the associations of BMI with CVD risk. In
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addition, data on BMI in relation to subtypes of stroke are
limited. There is increasing evidence that obesity is a risk factor
for ischaemic stroke.21-25 However, excess weight has not been
recognised as an established risk factor for stroke and generally
has not been included in the overall estimation of stroke risk.26-28
The association between BMI and haemorrhagic stroke is less
clear. Most studies inWestern populations have shown no21 29-32
or an inverse24 33 34 association, but several cohort studies have
reported a J or U shaped curve in Japanese and Korean
populations.25 35-39 Large prospective studies that better
characterise the shape of the association between BMI and
mortality for specific CVD in Asian populations could improve
our understanding, awareness, treatment, and control of this
major group of diseases.
There are several methodological issues in examining the
association between excess adiposity and CVD. Firstly, weight
loss resulting from illness may distort the relation between
leanness and health because of the bias often referred to as
reverse causation.40-42 Studies that did not exclude individuals
with history of disease, or that had a short follow-up, are more
prone to reverse causality.41 43 Secondly, cigarette smoking—an
established risk factor for CVD that is related to low BMI—may
confound the relation between BMI and CVD mortality.41 42
Recent studies inWestern populations have attempted to tackle
these methodological challenges, using offspring BMI as an
indicator of own BMI or a Mendelian randomisation
approach.44 45 However, these methods have not been extended
to assess non-linear associations. Owing to limited sample size,
few studies have explored the extent to which the association
between BMI and CVDmortality differs by smoking status and
in individuals without a history of CVD among Asian
populations. In addition, studies in Asian populations are needed
to evaluate potential mediation by risk factors such as
hypertension and diabetes, or potential effect modification by
age of the association between BMI and CVD risk.
We conducted a pooled analysis using data from 20 prospective
cohorts, involving more than 1.1 million participants from east
and south Asia with comparable BMI data in the Asia Cohort
Consortium, to characterise the shape of the association between
BMI and CVDmortality. The analyses included a large sample
size, allowing us to examine, in detail, the risk of CVD subtypes
across a wide distribution of BMI.
Methods
The Asia Cohort Consortium
Details of the Asia Cohort Consortium have been presented
elsewhere.46-48 Briefly, the Asia Cohort Consortium is an
international collaboration committed to the study of
environmental exposures and genetics in the aetiology of
disease. Cohorts were identified through a systematic search of
the literature in early 2008, followed by a survey that was sent
to each cohort to assess data availability.48 The Asia Cohort
Consortium includes more than 20 cohorts representing Japan,
China, Korea, India, Taiwan, Bangladesh, and Singapore. There
were no different ethnicities within each cohort. For the present
study, we included people from 20 cohorts with baseline data
for BMI, age, sex, and smoking status, and follow-up data for
deaths from any cause (table 1⇓).
Data for baseline BMI (calculated based on measured or self
reported height and weight, table 1), sex, age, date of birth,
cigarette smoking, alcohol drinking, and information on specific
CVD risk factors (including history of hypertension, diabetes,
stroke, and CHD at baseline) were collected from all cohorts
using structured questionnaires. Each cohort collected data for
follow-up time and cause specific deaths (using ICD-7
(international classification of diseases, 7th revision), ICD-8,
ICD-9, or ICD-10) through linkage to death registry or active
follow-up.
All data were transferred and harmonised at the Asia Cohort
Consortium coordinating centre at the Fred Hutchinson Cancer
Research Center. Harmonisation involved several rounds of
discussions to ensure that variables were correctly interpreted
and extracted. Data were checked for illogical or missing values
and queries sent back for clarification. The distributions of
individual variables were explored to identify false or
implausible values. All personal identifiers were removed, but
study specific identification numbers were retained to facilitate
all queries back to the individual cohorts.
Outcomes of interest included: cardiovascular disease (using
ICD-10 codes I00-I99; ICD-9 codes 390-459), whichwas further
categorised into coronary heart disease (ICD-10 codes I20-I25;
ICD-9 codes 410-414) and stroke (ICD-10 codes I60-I69; ICD-9
codes 430-438); as well as subtypes of stroke, including
ischaemic stroke and haemorrhagic stroke (web table 1).
Statistical analyses
Descriptive analyses were first conducted to describe the
characteristics of each cohort. To examine the shape of the
relation of BMI and mortality from overall cardiovascular
disease, CHD, total stroke, ischaemic stroke, and haemorrhagic
stroke, we estimated hazard ratios and 95% confidence intervals
based on Cox proportional hazards regression models that
combined studies in an individual-participant-data
meta-analysis.65-69 To reduce the likelihood of reverse causation,
all analyses excluded people and deaths with fewer than three
years of follow-up.
The primary analysis consisted of a Cox model for analysis of
individual participant data, stratified by cohort to account for
possible differences among cohorts in the baseline hazard.65 In
the models, the effect of BMI on mortality was taken to be
cohort specific, assuming that the log hazard ratio for BMI had
a fixed effect component in each cohort that was common to
all cohorts and a cohort-specific random effect that was normally
distributed with mean zero. Hazard ratios for mortality from
CVD and its subtypes were estimated in relation to BMI levels
separately for east Asians (China, Taiwan, Singapore, Korea,
and Japan), south Asians (Bangladesh and India), overall, and
inmen andwomen separately.We used the BMI range 22.5-24.9
(based on analyses of all cause mortality)48 as the reference.We
also established 10 levels of BMI levels in total (<15.0,
15.0-17.4, 17.5-19.9, 20.0-22.4, 22.5-24.9, 25.0-27.4, 27.5-29.9,
30.0-32.4, 32.5-34.9, and ≥35.0). Because data for stroke
subtypes from south Asian cohorts were limited, separate
analyses for ischaemic stroke and haemorrhagic stroke were
conducted for east Asians only.
Potential confounders included baseline age (<40, 40-49, 50-59,
60-69, 70-79, and ≥80 years), sex (except for stratified analyses
by sex), cigarette smoking (never v ever), alcohol consumption
(never v ever), educational attainment (no formal education,
primary, secondary, trade/technical, university degree,
postgraduate degree, other), marital status (single, married,
separated, widowed, divorced), and urban residence. Because
several cohorts did not collect information on marital status and
educational attainment at baseline, people with missing data for
these two variables were coded using dummy variables, allowing
their inclusion in the analyses under a “missing at random”
assumption.We also did sensitivity analyses to compare adjusted
and unadjusted results among people with non-missing values.
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These results were similar to the main analyses and are therefore
not shown.
We also conducted analyses using conventional BMI in three
categories: 15-18.4 (low), 18.5-24.9 (normal), and 25 and above
(high).70 Individuals with a BMI value lower than 15 were
excluded from subgroup analyses to be more comparable with
other studies.18 19 71 To evaluate the influence of specific potential
confounders and mediators, analyses were
conducted—excluding individuals with a history of CHD or
stroke at baseline—for the overall population and in never
smokers, and by baseline smoking status (ever, current, former,
and never). Additional stratified analyses by baseline age (<53
v ≥53 years; the median age of the east and south Asians
combined) were conducted to evaluate whether the influence
of BMI was similar in different age groups. Because diabetes
and hypertension are considered intermediate risk factors on
the causal pathway between BMI and CVD,20 71 72we conducted
separate models stratifying on, or adjusting for, these variables.
Results
From 20 cohorts, there were a total of 1 124 897 participants
and 49 184 CVD deaths (table 1). This group included 835 082
participants and 40 791 CVD deaths in east Asians, and 289
815 participants and 8393 CVD deaths in south Asians. Mean
BMI in the cohorts was 22.8, with cohort specific means ranging
from 19.8 in Bangladesh to 24.0 in the Community-based Cancer
Screening Project study in Taiwan. Mean BMI was 23.1 in east
Asians and 22.0 in south Asians. Participants were, on average,
53.4 years old at baseline, with a mean follow-up of 9.7 years.
Across all studies, 535 451 (47.6%) were men, and 386 965
(34.4%) were ever smokers at baseline. The enrolment period
started after 1980 for all cohorts except the Radiation Effects
Research Foundation cohort, which recruited participants from
1963. CHD mortality accounted for 29.3% (n=14 411) of total
CVD mortality, ranging from 17.6% (n=31) in Bangladesh to
62.8% (n=2643) in the Trivandrum cohort. Stroke accounted
for 41.9% (n=20 608) of total CVD mortality, ranging from
19.6% (n=785) in Mumbai to 61.7% (n=1040) in Shanghai.
All the analyses on BMI and CVD mortality excluded
participants and deaths with fewer than three years of follow-up
(n=17 026). In east Asians, we observed a U shaped association
between BMI and overall CVD mortality (table 2⇓, fig 1⇓).
Elevated risk of death was observed for overall CVD at BMI
value 25 and above, compared with the reference range of
22.5-24.9 (hazard ratios 1.09 (95% confidence interval 1.03 to
1.15), 1.27 (1.20 to 1.35), 1.59 (1.43 to 1.76), 1.74 (1.47 to
2.06), and 1.97 (1.44 to 2.71) for BMI ranges of 25.0-27.4,
27.5-29.9, 30.0-32.4, 32.5-34.9, and 35.0-50.0, respectively).
Adjusted hazard ratios were lowest at BMI range 20.0-22.4 for
death from overall CVD, total stroke, and stroke subtypes, and
lowest at BMI range 17.5-19.9 for deaths from CHD. Elevated
hazard ratios were observed in all BMI categories greater than
24.9 for CVD, CHD, and ischaemic stroke. Compared with the
BMI reference range of 22.5-24.9, we noted greater hazard ratios
for death from CHD and ischaemic stroke, starting at range
25.0-27.4 (1.14, 1.04 to 1.24, for CHD; 1.21, 1.07 to 1.37, for
ischaemic stroke). The risk of death from total stroke and
haemorrhagic stroke was elevated, starting at BMI range
27.5-29.9, with a positive, dose-response association continuing
across higher BMI categories.
In the low BMI range (<17.5), BMI had an inverse relationship
with total CVD mortality. These individuals were more likely
to die from CVD than those with BMI values in the reference
range of 22.5-24.9 (BMI<15.0, hazard ratio 2.16 (95%
confidence interval 1.37 to 3.40); BMI 15.0-17.4, 1.19 (1.02 to
1.39); table 2). Very low BMI (<15.0) was associated with
increased risk of death from all CVD subtypes, although none
of the estimates was statistically significant. Stratified analyses
by sex showed similar patterns of the associations, with a
stronger association observed in men (web table 2).
In south Asians, we observed a positive association between
high BMI categories (>24.9) and cardiovascular death, although
this relation was not statistically significant andwas substantially
weaker than in east Asians (table 3⇓, fig 1). Individuals with a
lower BMI had a reduced risk of death from CVD. This risk
was lowest for individuals with BMI values in ranges 15.0-17.4
and 17.5-19.9, compared with those with values in the reference
range 22.5-24.9 (table 3).
We observed a similar pattern for death from CHD. BMI was
positively related to the risk of death from CHD in individuals
with BMI values above 24.9. Aweaker associationwas observed
in south Asians than in east Asians, with hazard ratios ranging
from 1.07 to 1.18—except for the highest BMI range of
35.0-50.0, with a hazard ratio of 1.90 (95% confidence interval
1.15 to 3.12; table 3). This hazard ratio was similar in east
Asians (1.88 (1.08 to 3.27), table 2). BMI values below 20 were
associated with about a 20% reduced risk for death from CHD.
On the other hand, we saw no association between BMI and
strokemortality in south Asians across the other BMI categories.
Stratified analyses by sex showed similar patterns (web table
3).
We also examined CVD mortality in three BMI categories:
15-18.4 (low), 18.5-24.9 (normal), and 25 and above (high) in
east Asians. East Asians with normal BMI values showed a
20% increased risk of death from CVD compared with those
with higher BMI values (fig 2⇓). The positive association was
similar among never, ever, and current smokers, but it was
weaker among former smokers. Excluding participants with a
history of CHD or stroke did not change the strength of
association appreciably. A greater risk of death from CVD was
associated with high BMI among individuals who were younger
than 53 at baseline (hazard ratio 1.38 (95% confidence interval
1.20 to 1.58)) than among individuals aged 53 and older (1.17
(1.10 to 1.25)). The estimate did not change appreciably with
additional adjustment for baseline diabetes status. On the other
hand, adjustment for baseline hypertension status attenuated
the association (1.07 (1.00 to 1.15)).
A stronger association was observed for CHD than for overall
CVD (fig 2). High BMI values (≥25) were associated with a
38% higher risk of death from CHD, and the difference in risk
was greater among individuals younger than 53 years (hazard
ratio 1.62 (95% confidence interval 1.33 to 1.97)). The higher
risk was attenuated, but remained statistically significant after
adjusting for baseline hypertension status and remained apparent
for individuals both with and without hypertension at baseline.
A weaker association was observed for stroke than for overall
CVD. High BMI was associated with a 14% increase in risk of
death from overall stroke, 28% from ischaemic stroke, and 9%
from haemorrhagic stroke (fig 2). The higher risk for total stroke
and stroke subtypes associated with higher BMI was seen in
never smokers and individuals younger than 53 years, although
the association for haemorrhagic stroke in those younger than
53 years was not statistically significant. Adjustment for
hypertension at baseline attenuated the risk, especially the risk
of haemorrhagic stroke. High BMI was not related to a
statistically significant higher risk of death from haemorrhagic
stroke in individuals who were older, ever-smokers, or
hypertensive at baseline.
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Compared with normal BMI values (range 18.5-24.9), low BMI
(15-18.4) was associated with an increased risk of death from
overall CVD (fig 3⇓). The higher risk of death from overall
CVD was observed in all subgroups and persisted after
adjustment for hypertension. There was insufficient evidence
indicating that low BMI was related to the risk of death from
CHD, overall, or in subgroups. The higher risk of stroke
associated with low BMIwas seen only in individuals who were
ever smokers or hypertensive at baseline. Associations for stroke
subtypes were weak or absent.
We did similar analyses in south Asians (figs 4⇓ and 5⇓), and
observed weaker associations than in east Asians. High BMI
values (≥25) were associated with an 8% and18% increased
risk of death from overall CVD and CHD, respectively (fig 4).
The positive association remained in never smokers, but was
weaker after excluding individuals with a history of CVD, and
was attenuated after adjustment for hypertension status at
baseline. Low BMI values (15-18.4) in south Asians was
associated with a 10% and 14% reduced risk of death from
overall CVD and CHD (fig 5), respectively, and the association
remained similar in never smokers and in individuals free of
CHD and stroke at baseline. The data did not suggest that high
or low BMI was related to the risk of death from stroke in south
Asians.
Discussion
Principal findings of the study
In this pooled analysis of prospective cohorts involving 1.1
million participants, we observed a U shaped association
between BMI and risk of death from CVD in east Asians. An
increased risk of death was observed in all BMI values greater
than 24.9 for overall CVD, CHD, and ischaemic stroke, and
values greater than 27.4 for overall stroke and haemorrhagic
stroke, as well as values lower than 17.5 for overall CVD. The
increased risk of death from overall CVD associated with high
BMI (>24.9) in east Asians was stronger among individuals
younger than 53 years. This increased risk was seen among
never smokers, individuals free of CVD at baseline, and
individuals without hypertension. Adjustment for hypertension
attenuated the risk, especially the risk of death from stroke. In
south Asians, the association between BMI and death fromCVD
seemed weak.
Comparison with other studies
In the Prospective Studies Collaboration (PSC), which included
mostly cohorts from Western countries, BMI was positively
and roughly log-linearly related to CHD mortality throughout
the BMI range of 20-40, with the lowest risk observed at about
20-22.5.71 Similarly, in the Emerging Risk Factors Collaboration,
with data on fatal and non-fatal CVD endpoints frommore than
220 000 individuals in cohorts predominantly from Europe and
the United States, a dose-response association was observed
between BMI and risk of CVD, CHD, and ischaemic stroke, in
those with BMI of 20 or higher.73 In east Asians, we observed
a similar positive association for CHD mortality in the upper
BMI range, with the lowest risk noted at the same BMI range
of 20-22.4. However, these data did not suggest a dose-response
relationship for BMI values above 30. The PSC showed a
positive association in the upper BMI range (values 25-50) for
death from ischaemic and haemorrhagic stroke; stroke mortality
was flat across the lower BMI range of 15-25.71 The pattern was
similar in our analyses for east Asians.
Several meta-analyses or pooled analyses of cohort studies have
assessed the association between BMI and CVD mortality in
east Asians. However, few studies have evaluated the strength
and shape of the association in more specific categories of BMI
and for subtypes of CVD. In the Asia Pacific Cohort Studies
Collaboration (APCSC), including data from 245 881 east
Asians, every five unit increase in BMI was associated with a
hazard ratio of 1.36 (95% confidence interval 1.17 to 1.59) for
CHD mortality,74 but there was no association with mortality
from either ischaemic stroke (1.07, 0.87 to 1.37) or
haemorrhagic stroke (0.95, 0.79 to 1.14).74 However, BMI was
considered as a continuous variable across all levels. In a study
that included 1 213 829 Koreans,18 the risk of death from CVD
rose steadily with increasing BMI values from 18. In a 2012
study of 220 000 Chinese men, a 61% and 48% increase in
stroke and CHDmortality, respectively, was observed for every
five unit increase in the upper BMI range (23.5 to 35), whereas
no association was observed in the lower range (15 to 23.5).19
Taken together, the body of literature suggests that the relation
between high BMI and CVD mortality is thus largely similar
in east Asians and Western populations. This is also consistent
with findings from a comparison between east Asians and
populations in Australia and New Zealand.74 Although the data
in the present study are largely consistent with previous studies
in east Asians, we also show that higher BMI is an important
risk factor, not only for CHD mortality but also for death from
ischaemic stroke and haemorrhagic stroke in east Asians.
A 2013 meta-analysis of 97 studies encompassing 2.88 million
individuals, mostly from cohorts inWestern countries, reported
a higher risk of death from any cause associated with obesity
(BMI ≥30) and a slightly lower risk (hazard ratio 0.94 (95%
confidence interval 0.91 to 0.96)) for overweight people (BMI
25-30), compared with people within a normal BMI range of
18.5-25.75 In our previous pooled analyses of 1.1 million people
in 19 cohorts in Asia, risk of death from any cause was also not
elevated in east Asians with a BMI value between 25.1 and 27.5.
However, we observed an increased risk in east Asians with a
BMI 27.6-30.0 or above,48 but no excess risk associated with
BMI higher than 25 in south Asians. As discussed, in east Asians
and Westerners, consistently higher risk of death from CVD
mortality was observed in all BMI categories greater than 25,
and those with BMI values between 20 and 22.4 had the lowest
risk. These data suggest that the association between higher
BMI and mortality differs by race and causes of death, and that
overweight may be a more important risk factor for CVD
mortality. Given that CVD is the leading cause of death, global
conclusions and recommendations for all groups and all diseases
seems inadvisable.
We also observed a higher risk in individuals with a BMI value
lower than 17.5. Individuals with markedly low (<16) or
moderately low (16-16.9) values of BMI were excluded from
previous large cohort studies of Korean and Chinese as well as
from pooled analyses of Western cohorts.18 19 71 The Emerging
Risk Factors Collaboration showed an increased risk of fatal
and non-fatal CHD in individuals with BMI values less than
20, but all subsequent analyses were restricted to those with a
value of 20 or higher.73 In the APCSC, as mentioned earlier,
BMI was considered as a continuous variable across all levels,
and this analysis did not detect any increase in risk for BMI
values lower than 17.5.74 Several smaller individual cohort
studies in Japan and China have reported that BMI values of
less than 18 or 18.5 were related to an increased risk of death
from overall CVD,37CHD,37 76 total stroke,35 37 ischaemic stroke,36
and haemorrhagic stroke.35 37
A low BMI may indicate a low level of circulating total
cholesterol or triglycerides, which has been related to increased
risk of haemorrhagic stroke in several cohort studies.77-80 A low
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BMI may also indicate other anthropometric measures such as
a small thigh circumference (a risk factor for cardiovascular
and coronary heart disease recently identified in a Danish
cohort81) or a low amount of total fat free mass, which has been
related to total mortality.82 83 However, we did not have data on
lipid profile or other anthropometric measures to assess whether
the high risk associated with low BMI can be attributable to
these factors. Given that leanness is more prevalent in Asian
populations than in Western populations, additional research
using superior measures of amount and distribution of body fat
are needed.
Evidence suggests that Asian Indians have more fat—both total
and abdominal—for a given BMI than Europeans.84 85 It has
been shown that south Asians have a higher risk of diabetes at
a lower BMI than white populations.86 Given the effect of fat
and diabetes on CVD, a stronger association between BMI and
CVD mortality in south Asians than in Europeans would have
been expected. On the contrary, we found a weaker association
between BMI and CVD mortality in south Asians. Individual
cohorts from south Asia reported similar findings,62 87 and our
pooled analyses, with a large sample size and sufficient numbers
in each BMI category, probably exclude lack of power as an
explanation. The finding is also consistent with data from a
previous study that suggested that a BMI values greater than
25 were associated with low population attributable fraction of
CHD and stroke (<1%).88 In previous analyses, we also observed
a very weak association of higher BMI with the risk of death
from any cause, respiratory disease, or cancer in south Asians31;
therefore, the issue of competing risks does not explain the weak
association between BMI and CVD mortality in south Asians.
In the present study, the lowest risk of death among south Asians
from overall CVD and CHD was observed at the BMI range of
15.0-19.9, lower than the range of 20.0-22.4 associated with the
lowest risk among east Asians (table 3). Although using BMI
cut-off points based on race or ethnicity is not appropriate for
overall mortality,31 evidence of their consideration for cause
specific mortality is inconclusive. Taken together, our data stress
that future studies including other anthropometric measures
(such as waist circumference, thigh circumference, or waist to
hip ratio) will be particularly important in assessing CVD risk
in south Asians. Furthermore, BMI values associated with CVD
mortality in east Asians andWestern populations may not apply
to south Asians.
We found that, in east Asians, higher BMI was associated with
elevated risk of death from CVD in never smokers as well as
individuals free of hypertension, CHD, and stroke at baseline.
The pooled analyses of Western cohorts found that the positive
association of BMI and CVDmortality can be largely accounted
for by blood pressure, lipid profile, and diabetes.71 Consistent
with this, the adjustment for baseline hypertension status
attenuated the association between BMI and death from CVD
in our study. We calculated the mediation proportion89 and
estimated that 62.3%, 35.7%, and 92.4% of the association of
higher BMI with the risk of death from overall CVD, CHD, and
stroke, respectively, could be attributed to hypertension in east
Asians. Adjustment for diabetes status, on the other hand, did
little to attenuate the positive association. The elevated risk
associated with higher BMI was also greater among individuals
younger than 53 years, as opposed to those aged 53 and older,
a finding also consistent with data fromWestern cohorts.71 The
weaker association in individuals aged 53 and over is probably
a result of the weaker correlation between BMI and cholesterol
or blood pressure at these older ages.71 Taken together, our data
suggest that hypertension control is critical among east Asians
to prevent CVD mortality that is associated with a high BMI,
especially in middle age.
Strengths and limitations of the study
We were able to include data on a wider range of BMI values
than previous studies and a large number of CVD
events—including stroke—which is rare in individual cohorts.
This allowed us to examine the risk of CVD subtypes across
much finer categories of BMI. We were also able to conduct
subgroup analyses by smoking status and history of CVD and
assess potential mediation by hypertension and diabetes.
However, the present study had several limitations. Firstly, as
mentioned previously, although it can be assumed that
individuals with a high BMI have an elevated fat mass, BMI
does not distinguish between weight associated with muscle
and weight associated with fat. We could not evaluate the
influence of waist circumference or waist-to-hip ratio on CVD
mortality, because the information was available from only four
east Asian cohorts and none of the south Asian cohorts included
in the present study. Nonetheless, BMI can be considered the
most useful, albeit crude, measure of obesity at the population
level.
Secondly, we used mortality data, not incidence data. The use
of death certificates may involve some misclassification in
deaths due to different stroke subtypes. However, such errors
are not likely to been affected by BMI levels. Widespread use
of computed tomography scans in Japanese local hospitals since
the 1980s and routine use of computed tomography and
magnetic resonance imaging in Korea have probably made the
diagnosis of stroke subtypes based on death certificates
sufficiently accurate.90 A validation study in China has shown
that the registration system has good sensitivity in diagnosing
stroke.91Non-fatal CVD events remained unidentified and were
therefore misclassified as non-cases. Although we believe that
any misclassification of CVD deaths is unlikely to have been
affected by BMI levels, we cannot predict the exact direction
or extent of the potential bias with certainty. Future large studies
that include incidence data are needed.
Nonetheless, our findings are also in line with data from the
pooled analyses of 33 cohorts in Asia-Pacific region with a
much smaller sample size that included incidence data.20 Similar
to other studies of BMI and CVDmortality,71 history of diabetes
and hypertensionweremeasured at baseline only andwere based
on self reported data in some cohorts, which could underestimate
the mediating effects of hypertension and diabetes.
Finally, as with all observational studies, we cannot exclude the
possibility of unmeasured or residual confounding. Specifically,
higher BMI is related to higher educational status, better living
conditions, and better nutrition in south Asians. Although we
controlled for educational attainment in the analyses, potential
negative residual confounding due to socioeconomic status may
remain and partly account for the weak association between
BMI and CVD mortality in south Asians.
Possible implications and future research
We observed an increased risk of death from CVD in all BMI
values greater than 24.9 as well as values lower than 17.5 in
east Asians. In east Asians, higher BMI was a risk factor for
mortality from all subtypes of CVD—including CHD, ischaemic
stroke, and haemorrhagic stroke, particularly in middle age; the
association for stroke was largely explained by baseline
hypertension. In south Asians, a much weaker association was
observed than in east Asians. The findings stress the important
role of higher BMI in the increasing rates of death from CVD
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in Asia, which could be managed by policy and prevention
strategies. However, additional research with more refined
anthropometric measures is needed to better explain the elevated
risk observed at low BMI and the apparently weak association
among south Asians.
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28.829.341.949 18434.447.622.853.429.71963-2006Total (east and south
Asians) (n=1 124 897)
HEALS=Health Effects of Arsenic Longitudinal Study; CHEFS=China National Hypertension Survey Epidemiology Follow-up Study; SCS=Shanghai Cohort Study;
SMHS=Shanghai Men’s Health Study; SWHS=Shanghai Women’s Health Study; CBCSP=Community-based Cancer Screening Project study;
CVDFACTS=CardioVascular Disease risk FACtor Two-township Study; KMCC=Korea Multi-center Cancer Cohort; JACC=Japan Collaborative Cohort Study;
JPHC=Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases; RERF=Radiation Effects Research Foundation cohort;
TOCS=Trivandrum Oral cancer Screening trial.
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*BMI estimated using weight and height measured at enrolment. For other studies, weight and height were self reported.
†Included only people from the two major dialect groups of Chinese in Singapore—that is, the Hokkien and Cantonese, who originated from the contiguous
provinces of Fujian and Guangdong in the southern part of China, respectively.
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2013;347:f5446 doi: 10.1136/bmj.f5446 (Published 1 October 2013) Page 11 of 19
RESEARCH
Table 2| Association between BMI and CVD mortality in east Asians
Body mass index at baselineCause and No of
CVD deaths 35.0-50.032.5-34.930.0-32.427.5-29.925.0-27.422.5-24.920.0-22.417.5-19.915.0-17.4<15.0
All participants (n=820 439)
2435421016 66852 456136 344243 602229 861111 14421 6872032No of participants
per BMI category
CVD (n=38 738)


















































































































Analyses for the calculation of hazard ratios were adjusted for baseline age, sex, cigarette smoking, alcohol consumption, educational attainment, marital status,
urban residence, and baseline status of cancer. All analyses excluded first three years of follow-up.
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Table 3| Association between BMI and CVD mortality in south Asians
Body mass index at baselineCause and No of
CVD deaths 35.0-50.032.5-34.930.0-32.427.5-29.925.0-27.422.5-24.920.0-22.417.5-19.915.0-17.4<15.0
All participants (n=287 432)
13632251698816 19935 89458 51768 88559 39631 1856754No of participants
per BMI category
CVD (n=8190)




































































Analyses for the calculation of hazard ratios were adjusted for baseline age, sex, cigarette smoking, alcohol consumption, educational attainment, marital status,
urban residence, and baseline status of cancer. All analyses excluded first three years of follow-up.
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Figures
Fig 1 Association between BMI and CVD mortality in east Asians and south Asians. Analyses for the calculation of hazard
ratios were adjusted for baseline age, sex, cigarette smoking, alcohol consumption, educational attainment, marital status,
urban residence, and baseline status of cancer. All analyses excluded first three years of follow-up
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Fig 2 Subgroup analyses for the association between high BMI values (≥25) and CVD mortality in east Asians. Hazard
ratios were estimated in comparison to normal BMI values (18.5-24.9), with adjustments for baseline age, sex, cigarette
smoking, alcohol consumption, educational, marital status, urban residence, and baseline status of cancer, except for the
stratifying variable. All analyses excluded first three years of follow-up. *Analyses excluded people with missing information
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on history of CVD and data from the Radiation Effects Research Foundation cohort, three Prefecture Cohort Study Aichi,
and Shanghai Cohort Study, which did not have data on previous diagnoses of CHD and stroke
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Fig 3 Subgroup analyses for the association between low BMI values (15-18.4) and CVD mortality in east Asians. Hazard
ratios were estimated in comparison to normal BMI (18.5-24.9), with adjustments for baseline age, sex, cigarette smoking,
alcohol consumption, educational attainment, marital status, urban residence, and baseline status of cancer, except for the
stratifying variable. All analyses excluded first three years of follow-up. *Analyses excluded people with missing information
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on history of CVD and data from the Radiation Effects Research Foundation cohort, three Prefecture Cohort Study Aichi,
and Shanghai Cohort Study, which did not have data on previous diagnoses of CHD and stroke
Fig 4 Subgroup analyses for the association between high BMI values (≥25) and CVD mortality in south Asians. Hazard
ratios were estimated in comparison to normal BMI (18.5-24.9), with adjustments for baseline age, sex, cigarette smoking,
alcohol consumption, educational attainment, marital status, urban residence, and baseline status of cancer, except for the
stratifying variable. All analyses excluded first three years of follow-up. *Analyses excluded people with missing information
on history of CVD and data from Mumbai cohort, which did not have information on previous diagnoses of stroke, CHD,
and hypertension
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Fig 5 Subgroup analyses for the association between low BMI values (15-18.4) and CVD mortality in south Asians. Hazard
ratios were estimated in comparison to normal BMI (18.5-24.9), with adjustments for baseline age, sex, cigarette smoking,
alcohol consumption, educational attainment, marital status, urban residence, and baseline status of cancer, except for the
stratifying variable. All analyses excluded first three years of follow-up. *Analyses excluded people with missing information
on history of CVD and data from Mumbai cohort, which did not have information on previous diagnoses of stroke, CHD,
and hypertension
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